MANILA, Philippines - The discovery of the “miracle molecule” called nitric oxide (NO) in 1998 by UCLA professor of Pharmacology Dr. Louis J. Ignarro and two other collaborators awarded him the prestigious Nobel Prize in Medicine in 1998. NO, one of the most important discoveries in the history of cardiovascular medicine, may prevent bypasses and stents, the two most expensive protocols worldwide. In his book No More Heart Disease, Dr. Ignarro boasted and proved that “nitric oxide can prevent, even reverse, heart disease and strokes.”
Over the past decade, scientific research showed evidence that there is a direct relationship between nitric oxide and the amino acid, L-arginine. This compelling science is the foundation of ProArgi-9 Plus, which was formulated in collaboration with leading L-arginine researchers like Dr. Joseph Prendergast and other cardiovascular specialists whose pioneering exhaustive research on the proper application of L-arginine in promoting cardiovascular health enabled them to formulate the best L-arginine product on the market. L-arginine is the most effective known pre-curser to nitric oxide and is the main ingredient of Dr. Prendergast’s formula.
This natural supplement combines the latest technology and superior organic ingredients for heart health and regeneration, and to fight aging. It is an extremely effective proprietary blend of L-arginine and L-citrulline, which is metabolized to yield more L-arginine, and optimizes the ability of the endothelium (cardiovascular lining) to create additional nitric oxide (up to 36 hours), enhancing blood flow to deliver nutrients and oxygen throughout the body and promote healthy energy levels. This was validated by the Nobel Prize Research on Nitric Oxide (NO) led by Dr. Ignarro. He further said that this L-arginine/L-citrulline pathway is the superior pathway to the production of NO.
Medical results on the efficacy of L-arginine as a promising agent have been certified by 200,000 scientific clinical studies including that of the High Desert Heart Institute when it conducted in 2009 the most comprehensive human clinical study (with unprecedented 7,000 markers) ever done on a nutritional supplement. In the concluded all-inclusive human clinical study of ProArgi9 Plus, 33 high-risk heart failure patients were selected. All 33 patients in the study had reached the end of what medical science could do for them. They were at maximum drug levels, maximum supplemental oxygen, and maximum therapy. 60% of these patients were on the heart transplant list. At the High Desert Heart Institute, patients who were already using drugs to control high blood pressure further reduced systolic blood pressure by 13% and diastolic BP by 17%. These patients were able to lower or eliminate their drug treatment with the new protocol in only three months.
To know more about how ProArgi-9 Plus can be the new vitamins for your heart, call 355-4122; 09173444748; 09186367788.